Tuberculosis (TB) outcomes vary widely, from asymptomatic infection to mortality, yet most animal models do not recapitulate human phenotypic and genotypic variation. The genetically diverse Collaborative Cross mouse panel models distinct facets of TB disease that occur in humans and allows identification of genomic loci underlying clinical outcomes. We previously mapped a TB susceptibility locus on mouse chromosome 2. Here, we identify cathepsin Z ( Ctsz ) as a lead candidate underlying this TB susceptibility and show that Ctsz ablation leads to increased bacterial burden, CXCL1 overproduction, and decreased survival in mice. Ctsz disturbance within murine macrophages enhances production of CXCL1, a known biomarker of TB severity. From a Ugandan household contact study, we identify significant associations between CTSZ variants and TB disease severity. Finally, we examine patient-derived TB granulomas and report CTSZ localization within granuloma-associated macrophages, placing human CTSZ at the host-pathogen interface. These findings implicate a conserved CTSZ-CXCL1 axis in humans and genetically diverse mice that mediates TB disease severity. ### Competing Interest Statement The authors have declared no competing interest.

In the past two decades, tuberculosis (TB) prevention, testing, and treatment services have saved more than 79 million lives—averting approximately 3.65 million deaths last year alone from the world’s...

Tracking the impact of TB funding via USAID

Monocyte research reveals “doppelgänger” populations that resemble classical monocytes but differ in origin, function, or migration.

DIslodged by COVID early in the pandemic, tuberculosis is once again the infectious disease that takes the most lives each year. And the number of cases set a new record. What's going on?